BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

GNOMvsIDNAETF Comparison

ETF 1

GNOM

Global X Genomics & Biotechnology ETF

This fund is part of

BioTech & Genomics

-5.05%

Full GNOM fund page

VS

ETF 2

IDNA

iShares Genomics Immunology and Healthcare ETF

This fund is part of

BioTech & Genomics

-5.05%

Full IDNA fund page

Global X Genomics & Biotechnology ETF (GNOM) and iShares Genomics Immunology and Healthcare ETF (IDNA) belong to the same industry segment: BioTech & Genomics. In contrast, IDNA's top sector exposures are Healthcare and Non-Corporate. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.47% for IDNA. GNOM is up 52.77% year-to-date (YTD) with +$29M in YTD flows. IDNA performs better with 63.63% YTD performance, and +$107M in YTD flows. Run a side-by-side ETF comparison of GNOM and IDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

GNOM vs IDNA performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/30/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	GNOM IDNA	-1.05%+0.60%	+25.40%+30.05%	+52.77%+63.63%	+58.77%+70.87%	+98.83%+148.49%	-19.70%-11.19%
Flows	GNOM IDNA	+$11M+$39M	+$10M+$78M	+$29M+$107M	+$24M+$106M	-$92M+$84M	-$42M+$64M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	GNOM IDNA	+44.18%+40.70%	+32.73%+29.28%	+31.10%+25.96%	+34.24%+28.86%
Max drawdown	GNOM IDNA	-10.60%-8.56%	-18.16%-10.60%	-43.10%-29.33%	-68.81%-65.57%
Max drawdown duration	GNOM IDNA	23d27d	145d46d	674d347d	1821d1822d

Trading data

Create an account to view trading data

Join for free

	GNOM	IDNA
Last sale 10/30/2026 at 1:30 PM	$69.61	$42.76
Previous close 10/29/2026	$72.54	$42.99
Consolidated volume 10/29/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	GNOM	IDNA
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/30/2026 at 1:30 PM

Live

Closed

	GNOM	IDNA
Last price	$69.61	$42.76
1D performance	-4.04%	-0.54%
AuM	$112.92 M	$334.91 M
E/R	0.5%	0.47%

Characteristics

	GNOM	IDNA
Management strategy	Passive	Passive
Provider	Global X	iShares
Benchmark	Solactive Genomics Index	NYSE FactSet Global Genomics and Immuno Biopharma Index
N° of holdings	-	48
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	April 5, 2019	June 11, 2019
ESG	No	No

More GNOM data on Trackinsight

More IDNA data on Trackinsight

Exposure

Countries

GNOM

Data will be available soon

IDNA

USA

66.57%

Other

33.43%

Sectors

GNOM

Data will be available soon

IDNA

Healthcare

99.66%

Other

0.34%

Diversification

GNOM

Data will be available soon

IDNA

Total weight of top 15 holdings out of 15

64.14%

Top 15 holdings

Data as of January 1, 1970

GNOM

Data will be available soon

IDNA

Moderna, Inc.

11.20%

Twist Bioscience Corp.

7.70%

Iovance Biotherapeutics, Inc.

4.98%

Genmab A/S

3.98%

Revolution Medicines, Inc.

3.79%

Bayer AG

3.60%

Merck & Co., Inc.

3.32%

Takeda Pharmaceutical Co., Ltd.

3.30%

Regeneron Pharmaceuticals, Inc.

3.29%

Incyte Corp.

3.27%

Caris Life Sciences, Inc.

3.25%

Vertex Pharmaceuticals, Inc.

3.23%

BioNTech SE

3.08%

ImmunityBio, Inc.

3.08%

Exelixis, Inc.

3.06%

Frequently asked questions about GNOM and IDNA

GNOMvsIDNAETF Comparison

Global X Genomics & Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

GNOM vs IDNA performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the GNOM and IDNA ETFs performed in 2026?

As of October 30, 2026, GNOM is up 52.77% year-to-date (YTD), while IDNA has returned 63.63%. That puts IDNA better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or IDNA?

Year-to-date, the GNOM ETF saw +$29M in flows, compared to +$107M for IDNA.

Which ETF is more volatile: GNOM or IDNA?

Over the past year, GNOM had a volatility of 32.73%, while IDNA experienced 29.28%.

Which ETF is bigger: GNOM or IDNA?

As of October 30, 2026, GNOM holds $112.92 M in assets under management (AUM), while IDNA manages $334.91 M.

ETFs’ Next Act: From Access to Selection